Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Therapy for Alzheimer's Disease (Single-Arm, Open-Label)
TCTR20260320005Phase 2Not yet recruiting
- Sponsor
- Zibo 148 Hospital
- Start
- Mar 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Alzheimer's disease (AD), sponsored by Zibo 148 Hospital. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on TCTR20260320005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260320005.